Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

65
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
65
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

41
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

44
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
44
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

72
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
72
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Machine learning-based prediction of mortality and hospitalization in diabetic patients with heart failure with preserved ejection fraction: the GUARDIAN-P risk score.

European heart journal. Digital health·2026
Same author

Common human ALDH1B1 and ALDH2 variants increase neuroinflammatory response to a single ethanol dose in mice.

Science advances·2026
Same author

Integrating genetic and lifestyle determinants in a risk prediction model for esophageal squamous cell carcinoma in Taiwan.

Scientific reports·2026
Same author

Triglyceride-glucose index and subclinical left ventricular dysfunction across cardiovascular-kidney-metabolic syndrome stages: a 7-year retrospective cohort study.

Frontiers in endocrinology·2026
Same author

2026 Taiwan society of lipids and atherosclerosis consensus statement for the identification and management of patients receiving suboptimally tolerable statins.

Journal of the Formosan Medical Association = Taiwan yi zhi·2026
Same author

Long-Term Outcome of Secondary Gingivoperiosteoplasty Versus Alveolar Bone Grafting in Complete Cleft Lip and Palate.

Plastic and reconstructive surgery·2026

相关实验视频

Updated: Sep 18, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

776

在糖尿病心肌病中出现ALDH2酶缺乏.

Yang-Wen Hsieh1, An-Sheng Lee2, Kuo-Tzu Sung2,3

  • 1Department of Medical Research, Mackay Memorial Hospital, Taipei City 104, Taiwan.

International journal of molecular sciences
|June 26, 2025
PubMed
概括

糖尿病心肌病 (DCM) 由于东亚人中常见的ALDH2*2基因变异而恶化,损害了化物解毒并增加了心脏损伤. 像ALDH2激活剂和SGLT2抑制剂这样的疗法对这种高风险人群来说是有希望的.

关键词:
作为ALDH2激活剂的一种.缺少ALDH2酶的原因之一是缺少ALDH2酶.ALDH2*2 运营商的运营商东亚地区的人口.SGLT2 抑制剂的使用.糖尿病心肌病 糖尿病心肌病

更多相关视频

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

301
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.3K

相关实验视频

Last Updated: Sep 18, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

776
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

301
Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

10.3K

科学领域:

  • 心脏病学 心脏病学
  • 遗传学 是一个遗传学.
  • 生物化学 生物化学

背景情况:

  • 糖尿病心肌病 (DCM) 是一种严重的糖尿病并发症,在东亚人口中普遍存在.
  • 这种ALDH2*2基因变异会损害阿尔德海德排毒,通过氧化应激和炎症增加心脏损伤.

研究的目的:

  • 审查ALDH2缺乏在DCM中的病理作用.
  • 整合临床数据与机械洞察力,并评估敏感人群的治疗方法.

主要方法:

  • 综合临床观察的系统审查.
  • 在体外和体内生物实验模型的分析.
  • 评估新兴的治疗策略.

主要成果:

  • ALDH2*2在高血糖症中加剧氧化应激和线粒体功能障碍,导致心脏纤维化和功能衰退.
  • 携带ALDH2*2的携带者表现出对代谢压力的敏感性增加,使DCM恶化.
  • ALDH2激活剂 (例如Alda-1) 和SGLT2抑制剂 (例如empagliflozin) 显示出治疗潜力.

结论:

  • 缺少ALDH2显著导致DCM,特别是在东亚人群中.
  • 向治疗可以通过减少氧化应激和改善线粒体功能来减轻心脏损伤.
  • 需要进一步的临床试验来验证这些治疗方法对ALDH2缺乏的个体.